The Frederick National Laboratory for Cancer Research
The Frederick National Laboratory for Cancer Research (FNLCR) was established in 1971 under the National Cancer Act to provide rapid response capabilities and one-of-a-kind resources for the biomedical research community. Its scientists develop technologies and perform studies to support NCI’s mission, as well as the work of other NIH institutes. Like Los Alamos, Brookhaven, Sandia Labs, and others, it is a Federally Funded Research and Development Center (FFRDC), using this special contract with SAIC-Frederick, Inc. to cut red tape and bring public and private partners to the table in real time to solve difficult medical research challenges. Changes in how NCI and the biomedical community conduct and support research, however, and the kind of research that characterizes contemporary science, have created an opportunity to re-envision the role of a national laboratory devoted to cancer research. For this purpose, NCI recently established an advisory committee to help identify new projects and emerging needs that might benefit from the processes and resources available at Frederick. The committee, chaired by Zach W. Hall, Ph.D., former Executive Vice Chancellor for Research at the University of California, San Francisco, requested at its first meeting that NCI develop a strategic plan for FNLCR designed to achieve the full potential of the capabilities made possible through its designation as an FFRDC.
Explore the programs and facilities that make The Frederick National Laboratory for Cancer Research uniquely situated to address some of the most significant challenges faced in the field of cancer research: